Camp4 Therapeutics Corporation
CAMP
$2.02
$0.031.51%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/1/2025
-
TipRanks Financial Blog
3/29/2025
-
GuruFocus
3/28/2025
-
TipRanks Financial Blog
3/27/2025
-
Globe Newswire
3/18/2025
-
The Fly
3/18/2025
-
Globe Newswire
3/4/2025
-
Insider Monkey
3/4/2025
-
Insider Monkey
2/6/2025
-
Globe Newswire
1/13/2025
-
Globe Newswire
1/7/2025
-
The Fly
1/7/2025
-
Globe Newswire
12/26/2024
-
ETF Channel
12/10/2024
-
TipRanks Financial Blog
12/10/2024
-
The Fly
12/10/2024
-
Globe Newswire
12/6/2024
-
TipRanks Financial Blog
12/5/2024
-
TipRanks Financial Blog
12/5/2024
-
The Fly
12/5/2024
-
TipRanks Financial Blog
12/5/2024
-
The Fly
12/2/2024
-
Globe Newswire
11/21/2024
-
SeekingAlpha.com: All News
11/21/2024
-
TipRanks Financial Blog
11/21/2024
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Oct 6 and 10 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617-651-8867
Address
One Kendall Square
3rd Floor - Building 1400 West
Cambridge, MA 02139
3rd Floor - Building 1400 West
Cambridge, MA 02139
Country
Year Founded
Business Description
Sector
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product...
more